Study: bioTheranostics CancerTYPE ID Classifies 30 Main Tumor Types
bioTheranostics has published study results related to its 92-gene molecular classification test to aid in the determination of the origin of a tumor.
Read MorebioTheranostics has published study results related to its 92-gene molecular classification test to aid in the determination of the origin of a tumor.
Read MoreThe American Association for Clinical Chemistry is hosting a Webinar titled, A Q&A with the FDA on the RUO/IUO Draft Guidance.
Read MoreAccording to an article on Medical Page Today, reducing hospital-acquired infections saves $1.1 million on average.
Read More